Slayback Garners $50m Investment From Everstone

Backing For Complex Generics Firm Follows KKR’s $60m In 2016

 
• By David Wallace
  
Watch_Investment
Everstone has agreed to invest up to $50m in Slayback • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business